Drug intelligence / Profile preview

Nutrison

Development stage: Unknown
Lead developer: Nutricia
Administration: Enteral

Overview

Nutrison is a range of enteral tube feeding formulas designed for medical nutrition therapy in patients with disease-related malnutrition, particularly in critically ill individuals. It is classified as a food for special medical purposes (FSMP) and provides complete nutritional support via the gastrointestinal tract when oral intake is insufficient or impossible. The standard formulation delivers 1.26 kcal/mL and contains balanced macronutrients (proteins, carbohydrates, fats), vitamins, and minerals to meet daily requirements. Nutrison products are intended for use under medical supervision and are not suitable for parenteral administration. They are used primarily in hospital or clinical settings to manage malnutrition associated with acute or chronic illness[1].

Brand names: Nutrison

Beyond the preview

Go deeper on Nutrison.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrison.

Explore the full profile